ACAD reports encouraging second-quarter results as earnings and revenues beat estimates, driven by year-over-year growth in Nuplazid and Daybue sales.

Here is how Axon Enterprise (AXON) and Rolls-Royce Holdings PLC (RYCEY) have performed compared to their sector so far this year.